Banque Cantonale Vaudoise’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.7M | Sell |
101,425
-85,224
| -46% | -$3.95M | 0.19% | 98 |
|
2025
Q1 | $11.4M | Buy |
+186,649
| New | +$11.4M | 0.5% | 32 |
|
2024
Q3 | $8.36M | Sell |
161,522
-4,830
| -3% | -$250K | 0.34% | 57 |
|
2024
Q2 | $6.91M | Buy |
166,352
+21,443
| +15% | +$891K | 0.27% | 61 |
|
2024
Q1 | $7.86M | Buy |
144,909
+37,663
| +35% | +$2.04M | 0.31% | 60 |
|
2023
Q4 | $5.5M | Sell |
107,246
-13,462
| -11% | -$691K | 0.24% | 77 |
|
2023
Q3 | $7.01M | Sell |
120,708
-5,771
| -5% | -$335K | 0.35% | 52 |
|
2023
Q2 | $8.09M | Buy |
126,479
+10,784
| +9% | +$690K | 0.38% | 54 |
|
2023
Q1 | $8.02M | Buy |
115,695
+8,635
| +8% | +$599K | 0.39% | 46 |
|
2022
Q4 | $7.7M | Buy |
107,060
+29,249
| +38% | +$2.1M | 0.4% | 44 |
|
2022
Q3 | $5.53M | Sell |
77,811
-11,984
| -13% | -$852K | 0.32% | 59 |
|
2022
Q2 | $6.92M | Buy |
89,795
+16,644
| +23% | +$1.28M | 0.36% | 51 |
|
2022
Q1 | $5.34M | Buy |
73,151
+8,059
| +12% | +$589K | 0.23% | 82 |
|
2021
Q4 | $4.06M | Sell |
65,092
-3,029
| -4% | -$189K | 0.16% | 129 |
|
2021
Q3 | $4.03M | Buy |
68,121
+763
| +1% | +$45.2K | 0.17% | 109 |
|
2021
Q2 | $4.5M | Sell |
67,358
-1,113
| -2% | -$74.4K | 0.2% | 101 |
|
2021
Q1 | $4.32M | Sell |
68,471
-784
| -1% | -$49.5K | 0.22% | 93 |
|
2020
Q4 | $4.3M | Sell |
69,255
-11,669
| -14% | -$724K | 0.24% | 87 |
|
2020
Q3 | $4.88M | Sell |
80,924
-8,266
| -9% | -$498K | 0.31% | 58 |
|
2020
Q2 | $5.24M | Buy |
89,190
+41,395
| +87% | +$2.43M | 0.38% | 55 |
|
2020
Q1 | $2.66M | Buy |
47,795
+1,000
| +2% | +$55.7K | 0.23% | 90 |
|
2019
Q4 | $3M | Buy |
+46,795
| New | +$3M | 0.21% | 103 |
|